OSL dosimetry for dose verification of organs at risk in high-dose-rate brachytherapy

OSL dosimetry for dose verification of organs at risk in high-dose-rate brachytherapy - OSL dosimetry in high-dose-rate brachytherapy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000025904

Enrollment

Registered

2017-04-01

Start date

2017-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cervical cancer

Interventions

dosimetry during intra-cavitary brachytherapy

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Patients with cervical cancer who undergo intra-cavitary brachytherapy for cervical cancer

Exclusion criteria

Exclusion criteria: Unremarkable

Design outcomes

Primary

Measure	Time frame
Precision of dosimetry	—

Countries

Japan

Contacts

Public ContactHitoshi Hitoshi

Tokushima University Graduate School Institute of Biomedical Sciences

ikushima@tokushima-u.ac.jp088-633-9051

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026